secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2021-08-11T23:59:59+00:00
Accession:  0001193125-21-243344
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Mary T. Szela resigns from Coherus BioSciences board, no disagreement
------------------------------------------------------------------------------

- Mary T. Szela resigned from Coherus board effective August 5, 2021.
- Resignation not due to any disagreement with Company's operations, policies or practices.
- No replacement director has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000119312521243344/0001193125-21-243344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000119312521243344/d216907d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-243344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer